Zentalis Pharmaceuticals, Inc. (ZNTL)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

530 SEVENTH AVENUE, SUITE 2201 NEW YORK, NY 10018

Zentalis Pharmaceuticals, Inc operates as a biotechnology company. The Company focuses on developing clinically differentiated novel small molecule therapeutics, as well as discovers medicines for cancer patients. Zentalis Pharmaceuticals serves customers in the United States.

Data as of 2020-09-12
Market Cap1.164 Billion Shares Outstanding40.003 Million Avg 30-day Volume120.703 Thousand
P/E Ratio Dividend Yield EPS-4.02
Price/Sales Price cash flow ratio Price free cash flow ratio-18.6
Book Value5.33 Price to Tangible Book5.76 Alpha0.06
Short Interest Ratio % Short Interest to Float R-squared0.001826
BETA-0.641515 52-week High/Low59.32 / 22.0 Stddev0.326533
View SEC Filings from ZNTL instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 0 0 (0.0%) No data
Funds Holding: 62 0 16 (1.04%) No data
13F shares: 26.853 Million 0 15.115 Million No data
% Ownership 74.8442 42.1295 No data
New Positions: 61 16 No data
Increased Positions No data
Closed Positions No data
Reduced Positions No data
Total Calls 0 No data
Total Puts 0 No data
PUT/CALL Ratio No data No data
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

 
Zentalis Pharmaceuticals, Inc. Chart by YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

WhaleWisdom Alpha

Our Other Reporting & Analysis

Funds Holding ZNTL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ZNTL BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PINTO ALEXIS CHIEF LEGAL OFFICER

  • Officer
 0 2020-08-31 2

BLACKWELL KIMBERLY

  • Director
 0 2020-07-01 2

SUN ANTHONY Y PRESIDENT & CEO

  • Officer
  • Director
 3,119,982 2020-04-07 1

JOHNSON DAVID MICHAEL

  • Director
 110,648 2020-04-07 1

EPPERLY MELISSA B, CHIEF FINANCIAL OFFICER

  • Officer
 277,529 2020-04-07 1

GALLAGHER CAM

  • Director
 489,143 2020-04-07 1

BUNKER KEVIN D. CHIEF OPERATING OFFICER

  • Officer
 544,650 2020-04-07 1

VIKING GLOBAL INVESTORS LP

VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP

VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC

VIKING GLOBAL OPPORTUNITIES GP LLC

HALVORSEN OLE ANDREAS

OTT DAVID C.

SHABET ROSE SHARON

  • 10% Owner
 4,443,284 2020-04-03 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

PINTO ALEXIS - Officer CHIEF LEGAL OFFICER

2020-09-01 21:16:19 -0400 2020-08-31 A 275,000 a 275,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments